Regkirona

Pharamaceuticals, biotech Celltrion to conduct tests on Omicron variant detected in Korea

Biopharmaceutical powerhouse Celltrion Inc. plans to use its treatments to test the Omicron variant detected in Korea, according to a high-level com...

COVID-19 Celltrion to export COVID-19 treatment to Europe in 2021

South Korea’s pharmaceutical giant Celltrion Inc. is set to export its COVID-19 treatment Regkirona to Europe by the end of this year as it se...

Covid-19 treatment Brazil gives emergency use nod for Celltrion’s COVID-19 treatment

South Korean drugmaker Celltrion Inc. has added Brazil to the list of countries that have granted emergency use approval for its COVID-19 treatment ...

Covid-19 treatment Indonesia grants emergency use approval for Celltrion’s COVID-19 treatment

South Korean drugmaker Celltrion Inc. has received the Indonesian government’s permission for restricted use of its COVID-19 treatment Regkiro...

COVID-19 Celltrion’s COVID-19 treatment reduces incidence of severity by 70%

Celltrion Inc. on July 13 said that its COVID-19 treatment Regkirona has proven effective in reducing the incidence of severe cases of the virus by ...